Cargando…

Use of Magnetic Resonance Imaging to Identify Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis

IMPORTANCE: Immune checkpoint inhibitors (ICIs) have transformed the treatment paradigm for an ever-increasing number of cancers. However, their use has also led to the emergence of immune-related adverse events, such as ICI-induced inflammatory arthritis. A reproducible, reliable, and accessible mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subedi, Ananta, Williams, Sandra G., Yao, Lawrence, Maharjan, Suresh, Strauss, Julius, Sharon, Elad, Thomas, Anish, Apolo, Andrea B., Gourh, Pravitt, Hasni, Sarfaraz A., Gulley, James L., Kaplan, Mariana J., Katz, James D., Gupta, Sarthak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137682/ https://www.ncbi.nlm.nih.gov/pubmed/32101306 http://dx.doi.org/10.1001/jamanetworkopen.2020.0032

Ejemplares similares

Association between anti-interferon-alpha autoantibodies and COVID-19 in systemic lupus erythematosus
por: Gupta, Sarthak, et al.
Publicado: (2020)

Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management
por: Gupta, Sarthak, et al.
Publicado: (2019)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

The extracellular matrix as an adhesion checkpoint for mammary epithelial function
por: Katz, Elad, et al.
Publicado: (2007)

Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
por: Gatti-Mays, Margaret, et al.
Publicado: (2021)

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
por: Gourh, Pravitt, et al.
Publicado: (2009)

Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity
por: Madan, Ravi A, et al.
Publicado: (2012)

Immune checkpoint inhibitors in clinical trials
por: Sharon, Elad, et al.
Publicado: (2014)

Health disparities in systemic lupus erythematosus—a narrative review
por: Hasan, Bilal, et al.
Publicado: (2022)

Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report
por: Cardis, Michael A., et al.
Publicado: (2019)

Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer
por: Odeny, Thomas A, et al.
Publicado: (2022)

Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation
por: Joseph, Jacinth J., et al.
Publicado: (2020)

Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
por: Gourh, Pravitt, et al.
Publicado: (2010)

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival
por: Manitz, Juliane, et al.
Publicado: (2022)

An Unusual Presentation of Tuberculosis With Dysphagia
por: Subedi, Ananta, et al.
Publicado: (2022)

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report
por: Monge, Cecilia, et al.
Publicado: (2018)

Metabolic Checkpoints in Rheumatoid Arthritis
por: Pucino, Valentina, et al.
Publicado: (2020)

Experience With Dexmedetomidine Use in the Treatment of Dysautonomic Crisis in Familial Dysautonomia: An Off-Label Use
por: Subedi, Ananta, et al.
Publicado: (2022)

Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
por: KC, Ojbindra, et al.
Publicado: (2023)

Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity
por: Sieber, Brendan, et al.
Publicado: (2022)

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls
por: Arnett, Frank C, et al.
Publicado: (2010)

Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
por: Banerjee, Shubhasree, et al.
Publicado: (2017)

Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
por: Banerjee, Shubhasree, et al.
Publicado: (2017)

JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
por: Banerjee, Shubhasree, et al.
Publicado: (2017)

Anti–PD-L1 Treatment Induced Central Diabetes Insipidus
por: Zhao, Chen, et al.
Publicado: (2017)

Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE
por: Purmalek, Monica M, et al.
Publicado: (2019)

Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
por: Lind, Hanne, et al.
Publicado: (2020)

Vaccinating against cancer: getting to prime time
por: Chang, Ryan, et al.
Publicado: (2023)

Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis
por: Desai, Shailey S, et al.
Publicado: (2012)

Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
por: Spillane, Susan, et al.
Publicado: (2020)

Changes in cardiorespiratory function and fatigue following 12 weeks of exercise training in women with systemic lupus erythematosus: a pilot study
por: Hasni, Sarfaraz, et al.
Publicado: (2022)

Clinical Images: Cardiovascular magnetic resonance to detect and monitor inflammatory myocarditis in systemic lupus erythematosus
por: Pamuk, Omer N., et al.
Publicado: (2021)

Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature
por: Cordes, Lisa M., et al.
Publicado: (2019)

Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa
por: Tsai, Yo-Ting, et al.
Publicado: (2022)

Non-synergy of PD-1 blockade with T-cell therapy in solid tumors
por: Davies, John S, et al.
Publicado: (2022)

Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma
por: Evens, Andrew M., et al.
Publicado: (2022)

Encephalomyeloneuritis and arthritis after treatment with immune checkpoint inhibitors
por: Nowosielski, Martha, et al.
Publicado: (2020)

Efficacy and immune-related adverse event associations in avelumab-treated patients
por: Kelly, Karen, et al.
Publicado: (2020)

Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report
por: Hitawala, Asif Ali, et al.
Publicado: (2023)

Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus
por: Rahman, Saifur, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2n7kfoottfjgbkj9elkdriv3b7